Ciba India Ltd - Stock Valuation and Financial Performance

Name: Ciba India
Brand: Ciba India

BSE: 532184 | NSE: CIBASPEC | Chemicals | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Ciba India

Based on:

Data

M-Cap below 100cr DeciZen not available

Ciba India stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

438.3 Cr.

52-wk low:

321

52-wk high:

332.9

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Ciba India:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	TTM
ROCE % ⓘ	19.4%	13%	14.5%	10.4%	7.3%	13%	16.4%	15.8%	7.1%	8.3%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	440	480	478	488	454	561	624	511	468	506	445
Sales YoY Gr.	-	9.2%	-0.6%	2.2%	-6.9%	23.4%	11.3%	-18.1%	-8.4%	8.1%	-
Adj EPS ⓘ	13.8	10.1	17.5	14.1	10.2	20.2	25	29.3	15.4	18.8	-22
YoY Gr.	-	-26.7%	72.5%	-19.5%	-27.8%	99.1%	23.5%	17.3%	-47.5%	21.9%	-
BVPS (₹) ⓘ	75.9	90.4	109.8	119.1	125.7	139.9	157	211.8	222.3	235	220.2
Adj Net Profit ⓘ	18.4	13.5	23.2	18.7	13.5	26.9	33.2	38.9	20.4	24.9	-29
Cash Flow from Ops. ⓘ	24.1	5.2	23.4	-2.9	48.7	39.1	35.6	-8.9	23.6	7.6	-
Debt/CF from Ops. ⓘ	1	11.7	2.4	-27.9	1.7	0.6	0.1	-0.9	1	0.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	1.6%	2.2%	-6.7%	8.1%
Adj EPS ⓘ	3.5%	13.1%	-9.1%	21.9%
BVPSⓘ	13.4%	13.3%	14.4%	5.7%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	TTM
Return on Equity % ⓘ	19.3	12.2	17.5	12.3	8.3	15.2	16.8	15.9	7.1	8.2	-9.7
Op. Profit Mgn % ⓘ	7.6	5.6	6.7	6.8	5.4	8	8.2	6.4	6.9	7.4	-1.3
Net Profit Mgn % ⓘ	4.2	2.8	4.9	3.8	3	4.8	5.3	7.6	4.4	4.9	-6.6
Debt to Equity ⓘ	0.2	0.5	0.4	0.5	0.5	0.1	0	0	0.1	0	-
Working Cap Days ⓘ	101	113	129	144	162	128	133	155	160	163	0
Cash Conv. Cycle ⓘ	42	60	74	87	97	72	62	65	59	56	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Net Profit has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Ciba India Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-22	24.7
TTM Sales (₹ Cr.)	445	692
BVPS (₹.) ⓘ	220.2	298.1
Reserves (₹ Cr.) ⓘ	279	383
P/BV ⓘ	1.50	1.11
PE ⓘ	0.00	13.37

From the Market
52 Week Low / High (₹)	321.00 / 332.85
All Time Low / High (₹)	47.00 / 669.90
Market Cap (₹ Cr.)	438
Equity (₹ Cr.)	13.3
Face Value (₹)	10
Industry PE ⓘ	53.3

Management X-Ray of Ciba India:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Ciba India

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Ciba India

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Sales	439.82	480.35	477.60	488.22	454.44	560.56	624.04	511.03	468.19	506.27
Operating Expenses ⓘ	406.77	453.45	446	457.64	430.05	515.52	572.91	478.26	437.62	475.69
Manufacturing Costs	11.60	11.94	14.60	12.80	12.72	16.38	18.17	16.01	12.87	17.44
Material Costs	362.88	397.53	384.56	396.52	372.12	449.92	498.23	415.75	380.29	406.22
Employee Cost	12.38	17.14	17.79	19.31	20.30	20.66	24.15	20.59	18.02	20.39
Other Costs ⓘ	19.92	26.84	29.05	29.01	24.91	28.57	32.37	25.90	26.44	31.64
Operating Profit ⓘ	33.05	26.90	31.60	30.57	24.39	45.04	51.13	32.78	30.57	30.59
Operating Profit Margin (%)	7.5%	5.6%	6.6%	6.3%	5.4%	8.0%	8.2%	6.4%	6.5%	6.0%
Other Income ⓘ	7.69	30.37	31.70	14.92	14.31	8.63	10.38	9.85	9.50	11.08
Interest ⓘ	5.68	9.29	6.61	6.03	6.14	4.19	1.72	0.90	1.43	1.78
Depreciation ⓘ	10.94	13.55	12.81	12.05	11.84	10.05	9.07	7.89	6.84	9.55
Exceptional Items ⓘ	0	0	0	0	0	0	0	60.16	0	3.20
Profit Before Tax ⓘ	24.11	34.44	43.88	27.42	20.72	39.43	50.72	94	31.80	33.53
Tax ⓘ	6.04	5.96	6.21	8.29	5.94	12.31	17.35	12.90	12.46	11.17
Profit After Tax	18.07	28.48	37.68	19.13	14.78	27.12	33.36	81.10	19.34	22.36
PAT Margin (%)	4.1%	5.9%	7.9%	3.9%	3.3%	4.8%	5.3%	15.9%	4.1%	4.4%
Adjusted EPS (₹)	13.6	21.4	28.4	14.4	11.1	20.4	25.1	61.1	14.6	16.8
Dividend Payout Ratio (%)	33%	28%	32%	31%	36%	27%	28%	8%	24%	21%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Equity and Liabilities
Shareholders Fund	100.75	120.10	145.82	158.21	167	185.79	208.55	281.28	295.19	312.10
Share Capital ⓘ	13.28	13.28	13.28	13.28	13.28	13.28	13.28	13.28	13.28	13.28
Reserves ⓘ	87.47	106.82	132.54	144.93	153.71	172.51	195.27	268	281.90	298.82
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	24.52	61.07	56.65	81.07	83.93	21.53	3.04	7.63	24.07	1.21
Long Term Debt	24.52	61.07	56.65	81.07	83.93	21.53	3.04	7.63	24.07	1.21
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Trade Payables	41.13	54.11	46.15	63.99	51.53	74.82	111.12	53.03	76.40	71
Others Liabilities ⓘ	26.24	31.13	27.99	24.28	28.27	32.05	35.14	27.34	24.77	28.25
Total Liabilities ⓘ	192.64	266.41	276.60	327.54	330.73	314.19	357.85	369.29	420.43	412.56
Fixed Assets
Gross Block	96.64	104.73	106.42	116.22	119.92	124.45	124.90	114.42	118.88	134.80
Accumulated Depreciation	48.51	60.19	66.12	77.40	85.12	93.54	96.51	87.61	92.81	89.27
Net Fixed Assetsⓘ	48.13	44.54	40.30	38.81	34.80	30.91	28.39	26.81	26.07	45.54
CWIP ⓘ	1.85	1.59	1.17	0.66	1.11	1.93	6.88	12.57	13.17	0.22
Investmentsⓘ	16.78	43.69	63.69	63.69	100.42	62.12	63.92	135.18	150.86	138.01
Inventories	41.71	73.48	69.19	91.37	79.35	77.23	100.38	68.22	81.70	85.14
Trade Receivables	62.92	84.01	82.10	111.54	93.44	118.79	126.41	73.09	75.82	71.69
Cash Equivalents	0.39	0.30	0.31	0.78	3.34	5.75	3.49	1.43	1.32	0.63
Others Assetsⓘ	20.85	18.80	19.84	20.69	18.27	17.46	28.37	52	71.49	71.32
Total Assets ⓘ	192.64	266.41	276.60	327.54	330.73	314.19	357.85	369.29	420.43	412.56

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Cash Flow From Operating Activity ⓘ	24.14	5.21	23.41	-2.91	48.74	39.09	35.64	-8.88	23.55	7.57
PBT ⓘ	24.11	15.14	23.82	24.29	19.82	39.43	50.72	33.83	31.80	30.33
Adjustment ⓘ	16.60	19.95	18.10	15.60	8.58	10.40	5.49	2.01	1.85	5.45
Changes in Working Capital ⓘ	-6.05	-23.65	-9.26	-40.21	28.16	0.46	-0.97	-32.43	5.71	-11.78
Tax Paid ⓘ	-10.52	-6.23	-9.25	-2.59	-7.83	-11.20	-19.59	-12.29	-15.81	-16.42
Cash Flow From Investing Activity ⓘ	-27.83	-11.56	-3.97	-3.02	-36.39	36.08	-9.36	13.81	-31.93	21.84
Capex	-26.21	-8.19	11.17	-7.15	-7.31	-7.12	-11.59	-19.43	-9.89	-4.89
Net Investments	-1.96	-6.91	-20	0	-36.74	38.30	-1.80	-70.98	-15.60	8.77
Others ⓘ	0.35	3.55	4.86	4.13	7.65	4.91	4.03	104.21	-6.43	17.96
Cash Flow From Financing Activityⓘ	-0.91	5.76	-19.43	6.39	-9.79	-72.76	-28.54	-6.99	8.26	-30.10
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-5.01	-8.71	-6.23	-6.07	-5.90	-4.37	-1.72	-0.97	-0.49	-1.78
Dividend Paid ⓘ	-3.98	-5.98	-7.97	-11.95	-5.98	-5.31	-7.30	-9.30	-6.64	-4.65
Others ⓘ	8.07	20.45	-5.23	24.42	2.10	-63.08	-19.51	3.28	15.39	-23.67
Net Cash Flow ⓘ	-4.60	-0.59	0.01	0.47	2.56	2.40	-2.25	-2.06	-0.11	-0.69

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Ratios
ROE (%)	19.01	25.79	28.34	12.58	9.09	15.38	16.92	33.11	6.71	7.36
ROCE (%)	25.84	28.54	26.32	15.14	10.96	19.04	25.04	37.92	10.93	11.16
Asset Turnover Ratio	2.42	2.13	1.81	1.66	1.42	1.79	1.91	1.45	1.22	1.23
PAT to CFO Conversion(x)	1.34	0.18	0.62	-0.15	3.3	1.44	1.07	-0.11	1.22	0.34
Working Capital Days
Receivable Days	50	55	62	70	80	67	70	69	57	53
Inventory Days	37	43	53	58	67	49	50	58	57	60
Payable Days	48	43	46	49	55	50	68	72	62	66

Ciba India Ltd Stock News

Ciba India Ltd FAQs

What is the share price of Ciba India?

Company share prices are keep on changing according to the market conditions. The closing price of Ciba India on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Ciba India?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Ciba India stood at ₹438.3.

What is the P/E ratio of Ciba India?

The latest P/E ratio of Ciba India as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Ciba India?

The latest P/B ratio of Ciba India as of 01-Jan-1970 05:30 is 1.50.

What is the 52-week high and low of Ciba India?

The 52-week high of Ciba India is ₹332.9 and the 52-week low is ₹321.0.

What is the TTM revenue of Ciba India?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ciba India is ₹444.6 ( Cr.) .

About Ciba India Ltd

Ciba India, formerly known as Ciba Specialty Chemicals (India), is engaged in the manufacturing, selling and trading of a wide range of specialty chemicals. It was formed when the chemicals division of Hindustan Ciba-Geigy was hived off in 1996 and got its present name on December 19, 2007. The company is a part of Ciba, headquartered in Basel, Switzerland, with business interests in plastics, paper, automobiles, buildings, home and personal care products across more than 120 countries. The group's plant is located at Goa. The company offers specialty chemicals such as additives, coating chemicals, water treatment and paper treatment chemicals, home and fabric care chemicals and personal care chemicals to a number of industries including petrochemicals, lubricants, oil & gas, automobiles, paper, paints, plastics, inks, electronics material, packaging, water treatment, and home & personal care products.

The manufacturing facility located at Santa Monica in Goa is a global sourcing point for Ciba. Since March 2007, this facility manufactures UV absorbers. It continues to manufacture textile chemicals for Huntsman International (India) as a part of the agreement relating to sale of the erstwhile textile affects business. A research and technology center in Mumbai conducts specialized research and development activities. The business segments align closely with customer industries by offering integrated and complete solutions including a wide range of knowledge-based services and expertise and follow a tailored approach to individual customer needs creating strategic partnerships that link core competencies of the company with end-user markets. Virchow Drugs, a subsidiary, manufactures the antibacterial agent triclosan, which is used in personal care products like toothpaste, soaps and fabrics.

The registered office is located at Plot No. 37, Chandivali Farm Road, Chandivali, Andheri (East), Mumbai-400072.

Divisions:

Speciality chemicals segment - This segment includes coating chemicals, additives, water treatment and paper treatment chemicals, home and fabric care chemicals and personal care chemicals.
Other - The other segments include manufacture of under-contract and sourcing of products for exports.